Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1995 1
1996 1
2010 1
2013 1
2015 2
2016 5
2017 6
2018 14
2019 9
2020 9
2021 10
2022 5
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for henni chu
Search for Zhenni Chu instead (1 results)
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial.
Planquette B, Bertoletti L, Charles-Nelson A, Laporte S, Grange C, Mahé I, Pernod G, Elias A, Couturaud F, Falvo N, Sevestre MA, Ray V, Burnod A, Brebion N, Roy PM, Timar-David M, Aquilanti S, Constans J, Bura-Rivière A, Brisot D, Chatellier G, Sanchez O, Meyer G, Girard P, Mismetti P; CASTA DIVA Trial Investigators. Planquette B, et al. Chest. 2022 Mar;161(3):781-790. doi: 10.1016/j.chest.2021.09.037. Epub 2021 Oct 8. Chest. 2022. PMID: 34627853 Clinical Trial.
Technical Issues in Exercise Oximetry.
Abraham P, Henni S. Abraham P, et al. Ann Vasc Surg. 2022 Feb;79:e9-e10. doi: 10.1016/j.avsg.2021.09.021. Epub 2021 Oct 11. Ann Vasc Surg. 2022. PMID: 34648859 No abstract available.
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial.
Zuily S, Lefèvre B, Sanchez O, Empis de Vendin O, de Ciancio G, Arlet JB, Khider L, Terriat B, Greigert H, Robert CS, Louis G, Trinh-Duc A, Rispal P, Accassat S, Thiery G, Montani D, Azarian R, Meneveau N, Soudet S, Le Mao R, Maurier F, Le Moing V, Quéré I, Yelnik CM, Lefebvre N, Martinot M, Delrue M, Benhamou Y, Parent F, Roy PM, Presles E, Goehringer F, Mismetti P, Bertoletti L, Rossignol P, Couturaud F, Wahl D, Thilly N, Laporte S; COVI-DOSE investigators. Zuily S, et al. EClinicalMedicine. 2023 Jun;60:102031. doi: 10.1016/j.eclinm.2023.102031. Epub 2023 Jun 9. EClinicalMedicine. 2023. PMID: 37350990 Free PMC article.
Exercise oximetry in patients with arterial claudication.
Abraham P, Lesourd L, Guilleron C, Durand S, Ammi M, Henni S. Abraham P, et al. Atherosclerosis. 2018 May;272:243-244. doi: 10.1016/j.atherosclerosis.2018.02.032. Epub 2018 Mar 2. Atherosclerosis. 2018. PMID: 29523341 No abstract available.
[Macro-AST and myeloma: An incidental association?].
Lartigau-Roussin C, Paclet MH, Audin H, Toussaint B, Henni T, Raffray L. Lartigau-Roussin C, et al. Rev Med Interne. 2017 Mar;38(3):210-213. doi: 10.1016/j.revmed.2016.05.015. Epub 2016 Oct 13. Rev Med Interne. 2017. PMID: 27745940 French.
Protective role of the mitochondrial fusion protein OPA1 in hypertension.
Robert P, Nguyen PMC, Richard A, Grenier C, Chevrollier A, Munier M, Grimaud L, Proux C, Champin T, Lelièvre E, Sarzi E, Vessières E, Henni S, Prunier D, Reynier P, Lenaers G, Fassot C, Henrion D, Loufrani L. Robert P, et al. FASEB J. 2021 Jul;35(7):e21678. doi: 10.1096/fj.202000238RRR. FASEB J. 2021. PMID: 34133045
61 results